Xiangya Bio is a recombinant human collagen biomaterials R&D and manufacturing company. The firm focuses on products for wound repair and medical aesthetics. It develops and produces innovative class II and class III medical devices. The company is described as a manufacturing-oriented, innovation-driven medical device enterprise. Recently Xiangya Bio completed an A round financing. Investors collectively contributed nearly RMB 100 million, according to the report.

Total raised

$14M

Funding rounds

1

Latest round

Series A

Latest activity

May 2024